Sector Expert: Antony Pfaffle
Antony E. Pfaffle, M.D. has been a director of CorMedix since February 2007, was appointed interim chief scientific officer on Jan. 1, 2013, and chief scientific officer in July 2014. Dr. Pfaffle has been director of healthcare research at Bearing Circle Capital L.P., an investment fund, since May 2007. He is an advisory medical director for ParagonRx, an Inventiv company specializing in drug and device risk evaluation and mitigation. He was a managing director at Paramount BioCapital Inc. and senior vice-president of business development at Paramount BioSciences LLC from December 2005 to May 2007. Dr. Pfaffle was a principal and founder of Black Diamond Research, an investment research company, from July 2001 to December 2005. Dr. Pfaffle is an internist who practiced nephrology at New York Hospital-Weill Cornell Medical Center, Lenox Hill Hospital and Memorial Sloan-Kettering Cancer Center. Dr. Pfaffle received his M.D. from New York Medical College.